日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Economy

Pricing mechanism for drug firms in pipeline

By Tang Zhihao (China Daily)
Updated: 2011-03-16 11:14
Large Medium Small

BEIJING - China is likely to establish a unified pricing mechanism this year to control the prices of some pharmaceutical products included on the essential drugs list (EDL), according to a member of a drug reform commission.

Experts said the move would benefit the large domestic pharmaceutical companies and help improve the quality and safety of the nation's drugs.

Song Dacai, director of the medicine pricing section of the National Development and Reform Commission (NDRC) was quoted in the First Financial Daily as saying that EDL medicines with sufficient supply and stable market prices would be selected for the first batch of drugs to be incorporated into the new pricing system.

Song said the government hopes the pharmaceutical companies will pay more attention to improving services and the quality of their products rather than engaging in price competition. He did not reveal whether the mechanism would cover all 307 drugs on the EDL in the future.

Experts said a unified price mechanism would be quality-oriented. It would turn the attention of drug manufacturers away from simple price competition and make producers focus more strongly on combining reasonable prices with product quality and safety.

"It will be difficult for some branded pharmaceutical companies to compete with the smaller manufacturers if the government promotes the Anhui-based 'tender model'," said Guo Fanli, an analyst from the Industry Research Center at China Investment Consulting.

The Anhui-based 'tender model' was developed and used in East China last year as a means of controlling the prices of essential drugs. Under the system, those producers offering the lowest price in a bidding contest were awarded contracts to manufacture the stipulated medicines.

"The prices offered by some small drug manufacturers are so low that they would not even cover the production costs of the large manufacturers," Guo said.

Related readings:
Pricing mechanism for drug firms in pipeline Reform to offer more accessible healthcare
Pricing mechanism for drug firms in pipeline China announces 21% price cut on 162 medicines
Pricing mechanism for drug firms in pipeline Food, drug safety listed as top menu item for health experts
Pricing mechanism for drug firms in pipeline Country ramps up healthcare spending

"The model might not be helpful in improving drug quality and safety, because the bid winners might be small companies whose costs may be low, but whose products may also be substandard," said Guo.

Zhao Chao, chief executive officer of the pharmaceutical company Buchang Group, said that in the most extreme cases the price set by small companies would not even cover the packaging costs of larger companies.

Some sections of the media have reported that a number of large manufacturers have been forced to withdraw from some local markets, because they were unable to break even if they sold their products at the prices offered by the smaller players.

"We think the Anhui model may experience resistance from both the administrative body and patients," said Ding Ding, director of the research division at UBS Investment Bank.

A unified pricing system will benefit branded drug makers, according to experts. Meanwhile, it may also promote consolidation in the industry.

Larger companies may win contracts because of the higher quality of their products, but smaller producers may lose their competitive edge if a combination of quality and price is used as a basis for judgement, according to Guo.

"Companies may seek joint ventures to strengthen their position in the industry and increase market concentration."

Though officials said a unified pricing mechanism would benefit both manufacturers and patients, experts said the government should improve the monitoring process to ensure that prices are set at a reasonable level, said Guo.

The NDRC said on Monday that it would start a new round of nationwide inspections in April, and will focus on inspecting drug prices and fees for medical services.

分享按鈕
主站蜘蛛池模板: 伊人精品在线视频 | 亚洲国产美女视频 | 麻豆chinese极品少妇 | 好看的中文字幕 | 日韩视频在线观看一区二区 | 久久精品综合网 | 国产精品乱码久久久久久 | 欧美一区视频 | 中文字幕日韩视频 | 亚洲第一黄色 | 国产精品久久久久久亚洲毛片 | 国产三级视频在线播放 | 国产精品五区 | 国产91精品欧美 | 夜色成人网| 金8天国av| 天天躁夜夜躁狠狠躁 | 少妇一区二区视频 | 精品久久久久国产 | 午夜视频网站 | 精品日韩一区 | 久久女人天堂 | 亚洲草逼 | 极品久久久久久久 | 高清在线一区 | a级毛毛片| 日本亚洲最大的色成网站www | 久久99精品久久久久久 | 亚洲最大黄色网址 | 亚洲精品永久免费 | 99re6这里只有精品 | 亚洲综合精品 | 人人爽爽人人 | 99视频这里有精品 | 久草这里只有精品 | 成人深夜视频在线观看 | 久久久欧美 | 欧美一区亚洲一区 | 欧美精品在线一区二区三区 | 中文字幕第31页 | 国产拍拍 |